MX387268B - Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva. - Google Patents

Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva.

Info

Publication number
MX387268B
MX387268B MX2019008155A MX2019008155A MX387268B MX 387268 B MX387268 B MX 387268B MX 2019008155 A MX2019008155 A MX 2019008155A MX 2019008155 A MX2019008155 A MX 2019008155A MX 387268 B MX387268 B MX 387268B
Authority
MX
Mexico
Prior art keywords
bioadhesive substance
preparing
fibers
electrospunched
high content
Prior art date
Application number
MX2019008155A
Other languages
English (en)
Other versions
MX2019008155A (es
Inventor
Jens Hansen
Original Assignee
Afyx Therapeutics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afyx Therapeutics As filed Critical Afyx Therapeutics As
Publication of MX2019008155A publication Critical patent/MX2019008155A/es
Publication of MX387268B publication Critical patent/MX387268B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/16—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of unsaturated carboxylic acids or unsaturated organic esters, e.g. polyacrylic esters, polyvinyl acetate
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/02—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • D01F6/26—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from other polymers
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/62—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters
    • D01F6/625—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyesters derived from hydroxy-carboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Textile Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Artificial Filaments (AREA)
  • Nonwoven Fabrics (AREA)

Abstract

La presente invención se refiere a un método para preparar fibras electrohiladas, el método comprende v) disolver un polímero hidrofílico formador de fibra en un alcohol seleccionado de alcoholes C1-C3, vi) disolver una sustancia bioadhesiva en agua, en donde la sustancia bioadhesiva tiene una solubilidad en agua de 3 g/100 ml o más a 25°C o g/100 ml o más a 25°C, y en donde la sustancia bioadhesiva tiene una solubilidad en un alcohol seleccionado de alcoholes C1-C3 de 0.5 g/100 ml 10 o menos a 25°C o 0.1 g/100 ml o menos a 25°C, vii)añadir bajo agitación la solución resultante de ii) a la solución resultante de i), por lo que la sustancia bioadhesiva se precipita y se forma una suspensión homogénea, en donde la sustancia bioadhesiva se suspende como partículas, y viii) electrohilar la suspensión homogénea para obtener fibras hidrofílicas.
MX2019008155A 2017-01-23 2018-01-22 Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva. MX387268B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201770043 2017-01-23
PCT/DK2018/050010 WO2018133910A1 (en) 2017-01-23 2018-01-22 Method for preparing electrospun fibers with a high content of a bioadhesive substance

Publications (2)

Publication Number Publication Date
MX2019008155A MX2019008155A (es) 2019-11-07
MX387268B true MX387268B (es) 2025-03-18

Family

ID=58536695

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019008155A MX387268B (es) 2017-01-23 2018-01-22 Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva.

Country Status (14)

Country Link
US (1) US11045430B2 (es)
EP (1) EP3570822B1 (es)
JP (1) JP7353980B2 (es)
KR (1) KR102595001B1 (es)
CN (1) CN110290783A (es)
AU (1) AU2018209592B2 (es)
BR (1) BR112019014732A2 (es)
CA (1) CA3050026A1 (es)
DK (1) DK3570822T3 (es)
ES (1) ES2874787T3 (es)
IL (1) IL268185B2 (es)
MX (1) MX387268B (es)
RU (1) RU2019126497A (es)
WO (1) WO2018133910A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3154513T3 (da) * 2014-06-10 2020-01-27 Afyx Therapeutics As Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde
EP3570821B1 (en) 2017-01-23 2021-07-21 AFYX Therapeutics A/S Method for fabrication of a two-layered product based on electrospun fibres
WO2021072113A1 (en) 2019-10-08 2021-04-15 Afyx Therapeutics A/S Compositions for the delivery of proteins
ES2876401B2 (es) 2020-05-11 2024-04-05 Bioinicia S L Parches auto-adhesivos de fibras para la liberación controlada de bioactivos
JP2024542227A (ja) 2021-11-23 2024-11-13 アフリックス デベロップメント アー／エス 粘膜パッチおよびその使用方法
KR20240073700A (ko) 2022-11-18 2024-05-27 한국생산기술연구원 다공성 폴리 유산 미세섬유 및 이의 제조방법
WO2025051337A1 (en) 2023-09-06 2025-03-13 Afyx Development A/S Compositions and methods for treating and preventing oral cancer
KR20250066118A (ko) 2023-11-06 2025-05-13 한국생산기술연구원 두가지 기능성 물질이 담지된 다공성 셀룰로오스 아세테이트 섬유 구조체 및 이의 제조방법

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2134635Y (zh) 1992-08-18 1993-05-26 许竞新 具有连续响声的印刷鞭炮
DE4337152A1 (de) 1993-10-30 1995-05-04 Merck Patent Gmbh Verfahren zur Herstellung von wäßrigen Chitosan-Lösungen und -Gelen
US6753454B1 (en) 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor
PL356924A1 (en) 2000-01-28 2004-07-12 Smithkline Beecham Corporation Electrospun pharmaceutical compositions
CN1531418A (zh) 2001-03-22 2004-09-22 ���ض������о�Ժ 制造可溶性剂型
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7309498B2 (en) 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
US20030017208A1 (en) 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
TW200410714A (en) 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
AU2003265446A1 (en) 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
KR100564366B1 (ko) 2003-11-19 2006-04-07 재단법인서울대학교산학협력재단 나노 섬유형 부직포를 이용한 조직 재생용 차폐막 및 그의 제조 방법
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
EP1796822A4 (en) 2004-10-06 2008-09-17 Res Foundation Suny INTENSE FLOW FILTRATION MEDIA WITH LOW ENCRYPTION
US7390760B1 (en) 2004-11-02 2008-06-24 Kimberly-Clark Worldwide, Inc. Composite nanofiber materials and methods for making same
WO2006106514A2 (en) 2005-04-06 2006-10-12 Nicast Ltd. Electrospun dosage form and method of producing the same
US9011754B2 (en) 2006-12-05 2015-04-21 Nanyang Technological University Manufacturing three-dimensional scaffolds using electrospinning at low temperatures
JP2009041117A (ja) * 2007-08-06 2009-02-26 Nisshinbo Ind Inc 多糖類ナノファイバー
WO2009031620A1 (ja) 2007-09-05 2009-03-12 Taiyokagaku Co., Ltd. 水溶性電界紡糸シート
EP2271301A4 (en) 2008-03-27 2014-07-02 Agigma Inc METHOD AND COMPOSITIONS FOR THE DELIVERY OF FUNDS
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
US8535727B2 (en) 2009-02-25 2013-09-17 North Carolina State University Biodegradable non-woven fabric having plant virus encapsulated actives for drug delivery
US20110111012A1 (en) 2009-11-12 2011-05-12 Hemcon Medical Technologies, Inc. Nanomaterial wound dressing assembly
JP5912126B2 (ja) * 2010-11-26 2016-04-27 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルクＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｔｈｅ Ｗｉｔｗａｔｅｒｓｒａｎｄ， Ｊｏｈａｎｎｅｓｂｕｒｇ 医薬投与形態
CN102251317B (zh) * 2011-05-18 2013-01-16 东华大学 一种药物释放可控的电纺纤维的制备方法
WO2013165604A1 (en) 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
WO2014066297A1 (en) 2012-10-22 2014-05-01 North Carolina State University Nonwoven fiber materials
US9393216B2 (en) 2012-11-06 2016-07-19 University Of Washington Through Its Center For Commercialization Vaginal matrices: nanofibers for contraception and prevention of HIV infection
EP2810645B1 (en) 2013-06-06 2017-05-24 A. Sezai Sarac New Drug Delivery System
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
CZ308492B6 (cs) * 2013-10-25 2020-09-23 Contipro A.S. Kosmetická kompozice na bázi kyseliny hyaluronové, způsob její přípravy a použití
WO2015106342A1 (en) * 2014-01-15 2015-07-23 University Of Guelph Compositions and methods to encapsulate and control release of volatile organic compounds for increasing shelf-life of perishable products
US10080816B2 (en) * 2014-06-05 2018-09-25 University Of The Witwatersrand, Johannesburg Wound dressing
DK3154513T3 (da) 2014-06-10 2020-01-27 Afyx Therapeutics As Sammensætninger, der omfatter elektrohydrodynamisk opnåede fibre til administration af specifikke doseringer af en aktiv substans til hud eller slimhinde
JP2018501090A (ja) * 2014-12-12 2018-01-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 高効率ｐｍ２．５捕捉のための空気フィルタ
JP6606279B2 (ja) 2015-11-19 2019-11-13 エーエフワイエックス・セラピューティクス・エー／エス 適用部位における滞留時間が改善された、電気流体力学的に得られた繊維を含む医薬組成物

Also Published As

Publication number Publication date
ES2874787T3 (es) 2021-11-05
KR20190126306A (ko) 2019-11-11
NZ755185A (en) 2025-06-27
WO2018133910A1 (en) 2018-07-26
RU2019126497A3 (es) 2021-05-26
KR102595001B1 (ko) 2023-10-26
IL268185B2 (en) 2024-01-01
IL268185B1 (en) 2023-09-01
US11045430B2 (en) 2021-06-29
CN110290783A (zh) 2019-09-27
CA3050026A1 (en) 2018-07-26
JP2020506307A (ja) 2020-02-27
RU2019126497A (ru) 2021-02-24
BR112019014732A2 (pt) 2020-03-10
MX2019008155A (es) 2019-11-07
JP7353980B2 (ja) 2023-10-02
AU2018209592A1 (en) 2019-07-25
AU2018209592B2 (en) 2024-03-21
IL268185A (en) 2019-09-26
EP3570822A1 (en) 2019-11-27
DK3570822T3 (da) 2021-07-26
EP3570822B1 (en) 2021-05-05
US20190254986A1 (en) 2019-08-22

Similar Documents

Publication Publication Date Title
MX387268B (es) Metodo para preparar fibras electrohiladas con un alto contenido de una sustancia bioadhesiva.
EA201391284A1 (ru) Способ формования анионно-модифицированной целлюлозы и волокна, полученные этим способом
CY1117628T1 (el) Βιοδιασπωμενα συνθετα
MX346385B (es) Fieltros hibridos de nanofibras electrohiladas.
Yan et al. Self-healing and moldable material with the deformation recovery ability from self-assembled supramolecular metallogels
MY171305A (en) Production method for readily dispersible cellulose composition, readily dispersible cellulose composition, cellulose dispersion resin composition, and production method for water-based dispersant for cellulose
BR112012017019A2 (pt) velo de fiação contínua altamente funcional e fibras, contendo partículas, bem como processo para a sua produção
CY1120100T1 (el) Υδατοδιαλυτα υμενια τα οποια περιλαμβανουν αλγινικες ενωσεις χαμηλου ιξωδους
TR201909640T4 (tr) Hızlı fibrillenen liyosel elyaf ve bunun kullanımı.
RU2017146716A (ru) Способ образования наночастиц циклоспорина а/ циклодекстрина
EA201170552A1 (ru) Способ получения волокон на основе целлюлозы и волокна, полученные этим способом
RU2016144153A (ru) Волокна с наполнителем
JP2013507478A (ja) 低フィブリル化セルロース誘導体繊維を製造するプロセス
RU2014127494A (ru) Сигаретный фильтр и сигарета
RU2014146888A (ru) Поперечносшитое производное гиалуронана, способ его получения, гидрогель и микроволокна на его основе
CL2022003429A1 (es) Un método para consolidar un material fibroso con un polímero aglutinante de base biológica
MY205036A (en) Psychotropic agents and uses thereof
Khoo et al. A review of electrospinning process and microstructure morphology control
BR112017022821A2 (pt) solução aquosa homogênea de quitosana injetável apresentando um ph próximo do ph fisiológico
MX2015014321A (es) Estructuras de fibra de polimero hidroxilado que comprenden sales de alquisulfonato de amonio y metodos para fabricarlas.
Righi et al. Electrospinning of gelatin/PEO blends: Influence of process parameters in the nanofiber properties
SA519410274B1 (ar) تركيبة معلق سمكتيت سائلة وطريقة لتحضيرها
WO2019054970A3 (en) Method of producing plga fibers used as tissue scaffolds and the plga fibers produced with this method
EA201692291A1 (ru) Способ получения углеродных волокон из целлюлозных волокон
PE20181497A1 (es) Uso de un copolimero de acrilato como auxiliar de retencion en un procedimiento para fabricar un sustrato que comprende fibras celulosicas